Nome formal
Apolipoprotein B-100
Este artigo foi revisto pela última vez em
Este artigo foi modificado pela última vez em
14 de Maio de 2018.
At a Glance
Why Get Tested?
To help evaluate your risk of developing atherosclerotic heart disease
When To Get Tested?
When you have a personal or family history of heart disease and/or hyperlipidemia and your doctor is trying to determine your risk of developing cardiovascular disease; sometimes measured to help monitor treatment for hyperlipidemia or to help diagnose a rare Apo B deficiency
Sample Required?
A blood sample drawn from a vein in your arm

Note: This test is often ordered at the same time as other tests that require fasting (such as a LDL-C, HDL-C and triglycerides); therefore, you may be instructed to fast for 12 hours prior to having this test.

What is being tested?
Apo B-100 is a protein that is an essential part of the very low density lipoprotein (VLDL) and low density lipoprotein (LDL) complexes. Apolipoprotein B helps provide structural integrity to complexes and directs transport of the water-insoluable lipids (like cholesterol and triglycerides) that are part of the VLDL or LDL complex. Apo B is recognized by receptors found on the surface of many of the body's cells. These receptors promote the uptake of cholesterol into the cells.

There are actually two forms of Apolipoprotein B: Apo B-100 and Apo B-48. Apo B-48 is created in the intestines. It is an integral part of the structure of chylomicrons, large lipoproteins that are responsible for the initial transport of dietary lipids to the liver. In the liver, the body repackages the lipids and combines them with Apo B-100 (made in the liver) to form triglyceride-rich VLDL. In the bloodstream, an enzyme called lipoprotein lipase (LPL) removes triglycerides from VLDL to create first, intermediate density lipoproteins (IDL) and then, low density lipoproteins (LDL - the "bad" cholesterol). Each VLDL particle contains one molecule of Apo B-100, which is retained as VLDL shrinks to become the more cholesterol-rich LDL. Laboratory tests typically measure only Apo B-100, which is often reported simply as Apo B or Apolipoprotein B.

The cholesterol that LDL and Apo B-100 transport is vital for cell membrane integrity, sex hormone production, and steroid production. In excess, however, LDL can lead to fatty deposits (plaques) in artery walls and lead to hardening and scarring of the blood vessels. This atherosclerosis narrows the vessels and increases the risk of heart attack. The LDL cholesterol (LDL-C) test is routinely ordered as part of a lipid profile. It is usually calculated from the total cholesterol level and tends to be less reliable as triglyceride levels rise. Some labs will directly measure LDL-C levels.

Apo B-100 levels tend to mirror LDL-C levels, but unlike calculated LDL-C, Apo B-100 levels can be measured directly. Many experts think that Apo B-100 levels may eventually prove to be a better indicator of risk of atherosclerotic heart disease than LDL-C. Others disagree but feel that Apo B-100 and other emerging cardiac risk markers such as Apo A-I, Lp(a), and hs-CRP may offer valuable additional information.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

There is no special preparation needed for an Apolipoprotein B-100 test. However, this test is often ordered at the same time as other tests that do require fasting, such as a LDL-C, HDL-C and triglycerides. Therefore, the patient is often instructed to fast for 12 hours prior to having this test.
Accordion Title
Common Questions
  • How is it used?
    Apo B-100 levels are used, along with other lipid tests, to help determine an individual's risk of developing atherosclerotic heart disease and coronary artery disease (CAD). It is not used as a general population screen but may be ordered when a patient has a family history of heart disease and/or hyperlipidemia. It may be performed, along with other tests, to help diagnose the cause of hyperlipidemia, especially when someone has elevated triglyceride levels (preventing accurate LDL cholesterol calculations).

    Sometimes doctors will order both Apo A-I (associated with high-density lipoprotein (HDL) - the "good" cholesterol) and Apo B-100 levels to get a ratio of A/B to obtain additional risk information.

    Occasionally Apo B-100 levels may be ordered to monitor the effectiveness of lipid treatment. In rare cases, they may be measured to help diagnose a genetic problem that causes over- or under-production of Apo B-100.

  • When is it ordered?
    Apo B-100 may be measured, along with other lipid tests, when your doctor is trying to evaluate your risk of developing atherosclerotic heart disease and when you have a personal or family history of heart disease and/or hyperlipidemia, especially when you have significantly elevated triglyceride levels. Sometimes Apo B-100 is monitored when you are undergoing treatment for hyperlipidemia.
  • What does the test result mean?
    Elevated levels of Apo B-100 correspond to elevated levels of LDL-C and are associated with an increased risk of CAD. Elevations may be due to a high fat diet and/or decreased clearing of LDL from the blood. Increased levels of Apo B-100 are seen with hyperlipidemia and in those patients with:

    Apo B-100 levels may be decreased with any condition that affects lipoprotein production or affects its synthesis and packaging in the liver. Lower levels are seen with:

    • Drugs such as: estrogen ( in post-menopausal women), lovastatin, simvastatin, niacin, and thyroxine
    • Hyperthyroidism
    • Malnutrition
    • Reye syndrome
    • Weight reduction
    • Severe illness
    • Surgery
    • Abetalipoproteinemia (also called Apolipoprotein B deficiency or Bassen-Kornzweig Syndrome, a very rare genetic condition)
    • Cirrohsis

    A low ratio of Apo A-I to Apo B-100 (A/B) may indicate a higher risk of developing coronary artery disease.

  • Is there anything else I should know?
    Some elevations of Apo B-100 (and LDL-C) are due to mutations in the Apo B gene that cause it to produce Apo B-100 that is not recognized as easily by LDL receptors. This slows the clearing of LDL from the blood and increases the risk of heart disease.
  • Should my doctor be measuring Apo B-48?
    While researchers are looking into the role of chylomicrons (the lipoprotein that contains Apo B-48), there is currently no reason to measure Apo B-48.
  • What can I do to lower my Apo B-100?
    Diet and exercise changes that lower LDL levels (and increase HDL – the good cholesterol) will lower your Apo B-100 levels and decrease your risk of heart disease.
View Sources
S1
Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

S2
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

S3
Apolipoprotein B Mutation Detection [8 paragraphs]. ARUP's Guide to Clinical Laboratory Testing (CLT) [On-line information]. Available FTP: http://www.arup-lab.com/guides/clt/tests/clt_al68.htm#1872677

S4
Angelo, S., Reviewed (2001 November 21, Reviewed). Apolipoprotein B100 [12 paragraphs]. University of Pennsylvania Health System Encyclopedia [On-line information]. Available FTP: http://www.pennhealth.com/ency/article/003502.htm

S5
Gianturco, S. & Bradley, W. (1999). Pathophysiology of Triglyceride-Rich Lipoproteins in Atherothrombosis: Cellular Aspects [ 36 paragraphs]. Clin. Cardiol. 22, (Suppl. 11) 11-7-11-14 [On-line Journal]. Available as PDF file: http://www.clinicalcardiology.org/supplements/CC22S2/CC22S207.pdf

S6
Blanchear, M. (2000 April 22). Lipoprotein Interconversions [13 paragraphs]. University of Manitoba, Tutorials in Biochemistry [On-line information]. Available online

S7
(2001 October). Apolipoprotein B, Detecting Familial Hypercholesterolemia [11 paragraphs]. ARUP [On-line Technical Bulletin]. Available FTP: http://www.aruplab.com/testbltn/apolipopro.htm

S8
(2002 October 25, Updated). Apolipoprotein B100 [14 paragraphs]. MEDLINEplus Health Information [On-line information]. Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/003502.htm

S9
(2001 October 30). Bassen-Kornzweig Syndrome [13 paragraphs]. MEDLINEplus Health Information [On-line information]. Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/001666.htm

S10
Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby’s Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO., Pp 110-114.

S11
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Winter, W. and Harris, N. Chapter 21: Lipoprotein Disorders, pp 251-259.

S12
(2006 August). Abetalipoproteinemia [8 paragraphs]. Genetics Home Reference [On-line information]. Accessed on: 4/29/07 Available FTP: http://ghr.nlm.nih.gov/condition=abetalipoproteinemia

S13
Gandelman, G. (2007 February 7, Updated). Apolipoprotein B100 [11 paragraphs]. MedlinePlus Medical Encyclopedia [On-line information]. Accessed on: 4/29/07 Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/003502.htm

S14
Sondheimer, N. (2005 April 20, Updated). Bassen-Kornzweig syndrome [12 paragraphs]. MedlinePlus Medical Encyclopedia [On-line information]. Accessed on: 4/29/07 Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/001666.htm

S15
Kasper D, et al, eds. (2005). Harrision’s Principles of Internal Medicine 16th edition, McGraw Hill.